ST Pharm

237690 · KOSDAQ · ₩237690 · 에스티팜

₩77,200▼ ₩3,200 (3.98%)End-of-day · Oct 28, 2026 · End-of-day prices.
Trade
Alert me

Filings

  • Investor relations (IR) event기업설명회(IR)개최

    Predicted impact: Low

    Oct 27, 2026Open on DART
  • Preliminary earnings (consolidated)연결재무제표기준영업(잠정)실적(공정공시)

    Predicted impact: Medium

    Preliminary consolidated results after earnings notice; figures not given, so size unknown versus last year.

    Oct 27, 2026Open on DART
  • Investor relations (IR) event기업설명회(IR)개최

    Predicted impact: Low

    Oct 22, 2026Open on DART
  • Advance Notice of Earnings Results Disclosure결산실적공시예고

    Predicted impact: Low

    Oct 22, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Oct 8, 2026Open on DART
  • Major management matter relevant to investors투자판단관련주요경영사항(임상시험결과) (HIV-1 치료제 STP0404 임상 2a상 임상시험결과보고서(CSR) 수령)Oct 6, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(약식)Oct 2, 2026Open on DART
  • Major sales or supply contract단일판매ㆍ공급계약체결Sep 18, 2026Open on DART
  • Investor relations (IR) event기업설명회(IR)개최Sep 9, 2026Open on DART
  • Half-year report (Jun 2026)반기보고서 (2026.06)Aug 14, 2026Open on DART
  • Acquisition of Convertible Bonds (Including Overseas Convertible Bonds) After Issuance and Before Maturity전환사채(해외전환사채포함)발행후만기전사채취득Aug 11, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jul 31, 2026Open on DART
  • Investor relations (IR) event기업설명회(IR)개최Jul 27, 2026Open on DART
  • Preliminary earnings (consolidated)연결재무제표기준영업(잠정)실적(공정공시)Jul 27, 2026Open on DART
  • Investor relations (IR) event기업설명회(IR)개최Jul 23, 2026Open on DART
  • Advance Notice of Earnings Results Disclosure결산실적공시예고Jul 23, 2026Open on DART
  • Major management matter relevant to investors투자판단관련주요경영사항(임상시험결과) (HIV-1 치료제 STP0404 임상 2a상 임상시험 탑라인 결과)Jul 14, 2026Open on DART
  • Disclosure Related to Sustainability Management Report, etc. (Voluntary Disclosure)지속가능경영보고서등관련사항(자율공시)Jun 22, 2026Open on DART
  • Amended: Annual report (Dec 2025)[기재정정]사업보고서 (2025.12)Jun 2, 2026Open on DART
  • Quarterly report (Mar 2026)분기보고서 (2026.03)May 15, 2026Open on DART
  • Investor relations (IR) event기업설명회(IR)개최May 14, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Apr 30, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Apr 30, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Apr 30, 2026Open on DART
  • Investor relations (IR) event기업설명회(IR)개최Apr 27, 2026Open on DART
  • Preliminary earnings (consolidated)연결재무제표기준영업(잠정)실적(공정공시)Apr 27, 2026Open on DART
  • Investor relations (IR) event기업설명회(IR)개최Apr 23, 2026Open on DART
  • Advance Notice of Earnings Results Disclosure결산실적공시예고Apr 23, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Apr 23, 2026Open on DART
  • Amended: Cash dividend decision[기재정정]현금ㆍ현물배당결정Apr 21, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(약식)Apr 1, 2026Open on DART
  • Investor relations (IR) event기업설명회(IR)개최Mar 30, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Mar 30, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Mar 30, 2026Open on DART
  • Annual general meeting results정기주주총회결과Mar 26, 2026Open on DART
  • Report on Appointment, Dismissal, or Mid-Term Resignation of Independent Directors독립이사의선임ㆍ해임또는중도퇴임에관한신고Mar 26, 2026Open on DART
  • Notice on Grant of Stock Purchase Options주식매수선택권부여에관한신고Mar 26, 2026Open on DART
  • Audit report submitted감사보고서제출Mar 18, 2026Open on DART
  • Annual report (Dec 2025)사업보고서 (2025.12)Mar 18, 2026Open on DART
  • Major sales or supply contract단일판매ㆍ공급계약체결Mar 16, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Mar 13, 2026Open on DART
  • Investor relations (IR) event기업설명회(IR)개최Mar 6, 2026Open on DART
  • Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Mar 3, 2026Open on DART
  • Notice of shareholders' meeting주주총회소집공고Mar 3, 2026Open on DART
  • Shareholder Register Closure for Cash/Stock Dividend (Record Date) Decision현금ㆍ현물배당을위한주주명부폐쇄(기준일)결정Feb 26, 2026Open on DART
  • Cash dividend decision현금ㆍ현물배당결정Feb 26, 2026Open on DART
  • Shareholders' meeting called주주총회소집결의Feb 26, 2026Open on DART
  • Change in Revenue or Profit/Loss Structure of 30% or More (15% or More for Large Companies)매출액또는손익구조30%(대규모법인은15%)이상변동Feb 11, 2026Open on DART
  • Investor relations (IR) event기업설명회(IR)개최Feb 9, 2026Open on DART
  • Preliminary earnings (consolidated)연결재무제표기준영업(잠정)실적(공정공시)Feb 9, 2026Open on DART

Titles in Korean until English translations are added.

Also known as: ST Pharm / 에스티팜 / 237690 / KRX:237690

Source: KRX statistical information